Gene Therapy And Secondary Malignancies: Integration Site Analysis Can Only Be Part Of The Answer

 
• By Bridget Silverman
  
Integrating viral vectors allow for persistent effects of gene therapies, but risk insertional mutagenesis. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Drug Safety